• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.14% Nasdaq Down 1.78%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.46 Up 0.04(9.53%) 12:09PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.42
    Open:0.42
    Bid:0.45 x 2000
    Ask:0.45 x 100
    1y Target Est:5.00
    Beta:2.61727
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:0.42 - 0.47
    52wk Range:0.30 - 1.47
    Volume:581,765
    Avg Vol (3m):795,372
    Market Cap:24.29M
    P/E (ttm):N/A
    EPS (ttm):-0.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXAUp 9.53%24.29M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.32
    Quarterly EPS Est (Sep-15) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback